易瑞生物(300942.SZ)发布前三季度业绩，归母净利润1802.3万元，增长362.49%

Core Viewpoint - 易瑞生物 reported a significant increase in both revenue and net profit for the first three quarters of 2025, indicating strong financial performance and growth potential [1] Financial Performance - The company's operating revenue for the first three quarters reached 186 million yuan, representing a year-on-year growth of 17.45% [1] - The net profit attributable to shareholders was 18.02 million yuan, showing a remarkable year-on-year increase of 362.49% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 3.73 million yuan, reflecting a year-on-year growth of 137.78% [1] - Basic earnings per share were reported at 0.0449 yuan [1]